Skip to content Norwegian Medical Products Agency Norwegian Medical Products Agency

Submission of documentation for single technology assessment of pharmaceuticals

Published:

Changes

All new pharmaceuticals with Marketing Authorisation are subject to a single technology assessment (STA) before they can be publicly funded either by the Regional Health Authorities (Nye metoder) or under the National Insurance Scheme (folketrygden).

Contact us

Unit for HTA and general reimbursement

22 89 77 00

blaresept@noma.no

Unit for HTA hospital medicines

22 89 77 00

sykehus@noma.no